| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
In the preceding three months, 6 analysts have released ratings for Medical Properties Trust (NYSE:MPW), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 3 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Medical Properties Trust, presenting an average target of $4.75, a high estimate of $5.00, and a low estimate of $4.00. Observing a 14.46% increase, the current average has risen from the previous average price target of $4.15.
A comprehensive examination of how financial experts perceive Medical Properties Trust is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nate Crossett | Exane BNP Paribas | Lowers | Neutral | $4.00 | $6.00 |
| Michael Lewis | Truist Securities | Raises | Hold | $5.00 | $4.50 |
| Michael Carroll | RBC Capital | Announces | Sector Perform | $5.00 | - |
| Omotayo Okusanya | Deutsche Bank | Raises | Hold | $5.00 | $2.00 |
| David Toti | Colliers Securities | Raises | Neutral | $5.00 | $4.25 |
| Michael Lewis | Truist Securities | Raises | Hold | $4.50 | $4.00 |
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Medical Properties Trust's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Medical Properties Trust analyst ratings.
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: Medical Properties Trust's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -22.53%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Medical Properties Trust's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -322.73%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Medical Properties Trust's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -12.22%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Medical Properties Trust's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -4.92%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.53.
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MPW
